NVSCX | VEXRX | NVSCX / VEXRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 23 years | - |
Gain YTD | -1.245 | 10.414 | -12% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 598M | 23.9B | 3% |
Annual Yield % from dividends | 0.00 | 0.58 | - |
Returns for 1 year | 1.53 | 11.21 | 14% |
Returns for 3 years | -21.05 | -15.19 | 139% |
Returns for 5 years | -39.20 | 17.00 | -231% |
Returns for 10 years | -22.85 | 32.29 | -71% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFCX | 12.60 | 0.02 | +0.16% |
AlphaCentric Life Sciences & Hlthcare C | |||
TIOHX | 15.21 | N/A | N/A |
Nuveen International Opps I | |||
FRLAX | 19.22 | -0.07 | -0.36% |
Franklin Real Estate Securities Adv | |||
TRMIX | 32.68 | -0.22 | -0.67% |
T. Rowe Price Mid-Cap Value I | |||
BSMIX | 17.51 | -0.20 | -1.13% |
iShares Russell Small/Mid-Cap Idx Instl |